4166
J . Org. Chem. 1998, 63, 4166-4167
Sch em e 1a
Gen er a l Ap p r oa ch to th e Syn th esis of
Sa r p a gin e a n d Ajm a lin e Alk a loid s.
En a n tiosp ecific Tota l Syn th esis of
(+)-Ajm a lin e a n d Alk a loid G via th e
Asym m etr ic P ictet-Sp en gler Rea ction
J in Li and J ames M. Cook*
Department of Chemistry, University of WisconsinsMilwaukee,
Milwaukee, Wisconsin 53201
Received March 12, 1998
(+)-Ajmaline (1), which contains four heteroatoms, six
rings, and nine asymmetric centers, is a clinically important
indole alkaloid1,2 with historical significance3 and is related
to the sarpagine 3 bases. Alkaloid G (2), which was recently
isolated from plant cell cultures of Rauwolfia serpentina
Benth by Sto¨ckigt et al.4 after feeding experiments with
ajmaline, is also related to 3. Both of these bases are
structurally related by the presence of the quinuclidine ring
and the C5-C16 bond linkage. The absolute configurations
of the stereogenic centers at C3, C5, and C15 of members of
both the sarpagine and ajmaline class of indole alkaloids
are identical.
a
Reagents and conditions: (i) PhCHO, CH3OH, rt, 2 h; NaBH4; -30
to -10 °C, 3 h; (CH3O)2CHCH2CH2COOCH3, TFA, CHCl3, ∆, 12 h; (ii)
NaH, CH3OH, PhCH3, ∆, 4 h; HOAc, HCl, ∆ 12 h.
Sch em e 2
Three important reports on the synthesis of ajmaline have
appeared previously.5 The first was published by Masamune
* Ratio of 12a ,b to 12c,d from the anionic oxy-Cope rearrangement
was 3:2.
synthesis of ajmaline that has also resulted in a formal total
synthesis of alkaloid G.
The optically active (-)-Nb-benzyltetracyclic ketone 87 was
prepared in enantiospecific fashion from D-(+)-tryptophan
methyl ester 6 via a stereospecific Pictet-Spengler/Dieck-
mann protocol in an improved two-pot process. Conversion
of the carbonyl function of (-)-8 into the R,â-unsaturated
aldehyde moiety of 9 via the spirooxiranophenylsulfoxide
was accomplished in 90% overall yield8 (Scheme 1). The R,â-
unsaturated aldehyde (-)-9 (>98% ee) serves as the key
intermediate for the total synthesis of alkaloids in both the
sarpagine and ajmaline series, as illustrated above (Scheme
2).
When (-)-9 was stirred with 3-bromo-4-heptene 10 (R )
Et) at 0 °C under the conditions of a Barbier-Grignard
process, the products of 1,2-addition (allylic alcohol 11,
isolated as a mixture of diastereomers) and 1,4-addition
(diastereomers 12a ,b and 12c,d ) were obtained in a com-
bined yield of 90% in a ratio of 51 (11):49 (12).8 The ratio of
desired to undesired isomers from the 1,4-addition was 3:1
(see 12a ,b vs 12c,d ). The allylic alcohol 11 was easily
separated from the mixture by flash chromatography and
underwent the anionic oxy-Cope rearrangement at 150 °C
in 88% yield to provide the same C-15-functionalized tetra-
cyclic systems 12a ,b and 12c,d in a ratio of 3:2. The key
diastereomers could also be obtained by executing the
et al. in 1967 and involved 16 steps; this elegant approach
was not enantiospecific, and the yields were not reported in
some cases. Two years later, Mashimo and Sato converted
tryptophan into an intermediate employed by Masamune in
the earlier synthesis of ajmaline in order to provide a formal
total synthesis of this alkaloid. Van Tamelen in 1970 in his
biogenetic approach synthesized deoxyajmaline, and since
Hobson et al.6 had earlier converted deoxyajmaline to
ajmaline, another synthesis of 1 was completed. This
biogenetic route involved 17 steps, and the overall yield was
quite low. We wish to report the first enantiospecific total
(1) Brugada, J .; Brugada, P. Am. J . Cardiol. 1996, 78(5A), 69-75.
(2) Slowinski, S.; Rajch, D.; Zabowka, M. Przegl. lek. 1996, 53(3), 196-
8.
(3) Hamaker, L. K.; Cook, J . M. The Synthesis of Macroline-Related
Alkaloids. In Alkaloids: Chemical and Biological Perspectives; Pelletier,
S. W., Ed.; Pergamon Press: London, 1995; pp 23-84 and references cited
therein.
(4) Endreb, S.; Takayama, H.; Suda, S.; Kitajima, M.; Aimi, N.; Sakai,
S.; Sto¨ckigt, J . Phytochemistry 1993, 32, 725-730.
(5) For earlier syntheses of ajmaline see: (a) Masamune, S.; Ang, S. K.;
Egli, C.; Nakatsuka, N.; Sarkar, S. K.; Yasunari, Y. J . Am. Chem. Soc. 1967,
89, 2506-2507. (b) Van Tamelen, E. E.; Oliver, L. K. Bioorg. Chem. 1976,
5 309-326 . (c) Mashimo, K.; Sato, Y. Tetrahedron Lett. 1969, 11, 905-
906. For a synthesis of isoajmaline see: Mashimo, K.; Sato, Y. Tetrahedron
Lett. 1969, 11, 901-904.
(7) Cox, E. D.; Hamaker, L. K.; Li, J in; Yu, Peng; Czerwinski, K. M.; Li,
Deng; Cook, J . M. J . Org. Chem. 1997, 62, 44-61. Yu, Peng; Cook, J . M.
Tetrahedron Lett. 1997, 38, 6819-6822 and references cited therein.
(8) Fu, X.; Cook, J . M. J . Org. Chem. 1993, 58, 661-672.
(6) Hobson, J . D.; McCluskey, J . G. J . Chem. Soc. C 1967, 20, 2015-
2017.
S0022-3263(98)00476-9 CCC: $15.00 © 1998 American Chemical Society
Published on Web 06/06/1998